Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 10 | 98540425 | intron variant | C/T | snv | 0.40 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 10 | 99095945 | intron variant | C/T | snv | 1.5E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.120 | 10 | 99144391 | stop gained | G/A | snv | 1.2E-05 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 10 | 98555795 | intron variant | C/T | snv | 9.8E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558936 | intron variant | C/T | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558310 | intron variant | C/T | snv | 0.45 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98566249 | intron variant | A/G | snv | 0.45 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98584379 | intron variant | T/C | snv | 0.17 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98551693 | intron variant | T/C | snv | 5.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
10 | 98942980 | intron variant | G/A | snv | 0.16 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
1.000 | 0.040 | 10 | 98529811 | intron variant | T/C | snv | 3.5E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98560162 | intron variant | C/T | snv | 7.1E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98553285 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98559036 | intron variant | T/C | snv | 0.40 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98566996 | intron variant | T/A | snv | 0.85 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98573343 | intron variant | T/A | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98573018 | intron variant | C/A;G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98572956 | intron variant | C/G | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98572859 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98564824 | intron variant | T/C | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98558679 | intron variant | A/G | snv | 0.85 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98572539 | intron variant | C/A;G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98572499 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 10 | 98565888 | intron variant | T/G | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 10 | 98561991 | intron variant | T/C | snv | 0.84 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 |